Ferdi van der Pijl

Ferdi van der Pijl is a Senior Scientist at Acerta Pharma B.V., a member of the AstraZeneca Group, since June 2019. Prior to this role, Ferdi served as a Scientist at Aspen Pharmacare from August 2014 to May 2019, and completed a PhD at Radboud University Nijmegen between October 2009 and January 2014. Ferdi holds a Master of Science (M.Sc.) in Organic Chemistry from Radboud Universiteit Nijmegen (2007-2009) and a Bachelor of Science (B.Sc.) in Chemistry from Radboud University (2003-2007).